ANAPTYSBIO, INC (ANAB) › Operating IncomeANAPTYSBIO, INC (ANAB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2015: -$3.32M2016: -$3.02M2017: -$28.78M2018: -$66.72M2019: -$107.43M2020: -$23.88M2021: -$56.81M2022: -$115.15M2023: -$164.41M2024: -$114.95M2025: $47.90M$47.90M2015Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$47.90M+141.7%2024-$114.95M+30.1%2023-$164.41M-42.8%2022-$115.15M-102.7%2021-$56.81M-137.9%2020-$23.88M+77.8%2019-$107.43M-61.0%2018-$66.72M-131.8%2017-$28.78M-851.4%2016-$3.02M+8.9%2015-$3.32M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share